GE General Electric Co

All GE filings Filing statistics SEC Website

GE (NYSE:GE) drives the world forward by tackling its biggest challenges. By combining world-class engineering with software and analytics, GE helps the world work more efficiently, reliably, and safely. For more than 125 years, GE has invented the future of industry, and today it leads new paradigms in additive manufacturing, materials science, and data analytics. GE people are global, diverse and dedicated, operating with the highest integrity and passion to fulfill GE’s mission and deliver for our customers. www.ge.com

Company profile

Ticker

Exchange

NYSE

CEO

H. Lawrence Culp

Incorporated in

New York

Location

Massachusetts

Fiscal year end

Dec 31

Sector

Electronic Technology > Aerospace & Defense

Industry (SEC)

Electronic & Other Electrical Equipment (No Computer Equip)

Emerson Electric • Koninklijke Philips ...

SEC CIK

0000040545

Corporate docs

Articles of Incorporation & Bylaws

IRS number

140689340

GE stock data

S&P 500 1 month 1 year

Company financial data Financial data

Chart GE financial data

Download latest Excel data (2019 Q2) View latest Excel data (2019 Q2)

Quarter (USD)	Jun 19	Mar 19	Dec 18	Sep 18
Revenue	28.83B	27.29B	33.28B	29.57B
Net income	127M	3.59B	761M	-22.77B
Diluted EPS	-0.01	0.4	0.07	-2.62
Net profit margin	0.44%	13.15%	2.29%	-76.99%
Cash on hand
Cost of revenue	21.82B	20.35B

Annual (USD)	Dec 18	Dec 17	Dec 16	Dec 15
Revenue	121.62B	118.24B	119.47B	117.39B
Net income	-22.36B	-8.48B	7.5B	-6.13B
Diluted EPS	-2.62	-1.03	0.75	-0.61
Net profit margin	-18.38%	-7.18%	6.28%	-5.22%
Net change in cash		-4.83B	-22.35B
Cash on hand		43.3B	48.13B	70.48B
Cost of revenue		27.61B	25.04B	22.79B

Financial data from company earnings reports

Financial report summary

Competition

Canon • Ceradyne • Echelon • Applica • Leidos • E-Z-Em • Lucid • Sionix • Aktiebolaget Electrolux • Alere San Diego

Content analysis ?

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: AG, aging, Antitrust, Apex, Artificial, bargaining, biopharmaceutical, blade, Brent, budget, CARESCAPE, chronic, climate, CODM, comment, COMMISSIONWASHINGTON, Compression, correlation, CT, demonstrating, detailed, diagnose, disease, driver, drug, dynamic, Economy, facilitate, field, gigawatt, hearing, HV, HVDC, hydropower, importantly, innovation, innovative, insulin, investee, Israel, Israeli, leave, liable, lifecycle, macro, modernize, morbidity, movement, Navify, newer, opposed, outlined, pace, partly, patient, perfect, persistence, pose, proximity, PTC, ratified, recession, Reciprocating, reliant, repair, repeat, replead, resizing, restated, Revolution, rigor, Roche, sensitive, speculative, stake, steady, strive, Substation, successfully, tailored, temporarily, tentative, traffic, Tumor, turnaround, upcoming, variation, vi, voltage, worldwide, WTI

Removed: absence, ACE, AGP, allege, assurance, begun, carefully, cleared, collect, COMMENTARY, commonly, complex, consisted, consisting, contingency, DB, derecognition, deriving, Deutsche, disallowed, display, distribution, divested, divestiture, divided, DPP, drilling, enabled, enactment, enforceable, ensure, exceeding, expertise, explicit, failure, freely, GECGH, governing, highly, historic, implicit, improving, inclusion, initiated, installation, integrate, integrating, invested, judicial, learned, legally, legislation, lowered, machinery, megawatt, mining, offer, outpacing, owe, population, preceded, predecessor, preparation, pretax, private, provisional, quickly, recurring, refund, remeasurement, represented, responsibility, retrospectively, selective, shifted, ship, slower, statute, Structured, subprime, suggested, system, team, territorial, timely, transactional, translated, translational, unregistered, unresolved, utilized, VIE, volatility, WASHINGTON

From filing 10-Q 2019 Q2